Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.
2.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
3.
4.

Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release).

Faraone SV.

Expert Opin Pharmacother. 2007 Sep;8(13):2127-34. Review.

PMID:
17714065
5.

Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.

Brams M, Mao AR, Doyle RL.

Postgrad Med. 2008 Sep;120(3):69-88. doi: 10.3810/pgm.2008.09.1909. Review.

PMID:
18824827
6.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
7.

Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Martinez-Raga J, Knecht C, Szerman N, Martinez MI.

CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9. Review.

PMID:
23160939
8.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Review.

PMID:
18384709
9.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
10.
12.

Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications.

Hammerness PG, Surman CB, Chilton A.

Curr Psychiatry Rep. 2011 Oct;13(5):357-63. doi: 10.1007/s11920-011-0213-3. Review.

PMID:
21698412
13.

Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents.

Connor DF, Rubin J.

Drugs Today (Barc). 2010 May;46(5):299-314. doi: 10.1358/dot.2010.46.5.1450095. Review.

PMID:
20517532
14.

Adderall XR: long acting stimulant for single daily dosing.

Sallee FR, Smirnoff AV.

Expert Rev Neurother. 2004 Nov;4(6):927-34. Review.

PMID:
15853519
15.

Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.

Rostain AL.

Postgrad Med. 2008 Sep;120(3):27-38. doi: 10.3810/pgm.2008.09.1905. Review.

PMID:
18824823
16.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Review.

PMID:
19470858
17.

Racemic amphetamine sulfate (Evekeo) for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2015 Sep 28;57(1478):137-8. Review. No abstract available.

PMID:
26393827
Items per page

Supplemental Content

Support Center